Tang Capital Management LLC Crispr Therapeutics Ag Transaction History
Tang Capital Management LLC
- $1.54 Billion
- Q1 2025
A detailed history of Tang Capital Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Tang Capital Management LLC holds 266,500 shares of CRSP stock, worth $9.67 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
266,500
Previous 266,500
-0.0%
Holding current value
$9.67 Million
Previous $10.5 Million
13.55%
% of portfolio
0.59%
Previous 0.79%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$369 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$220 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$138 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$101 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$92.2 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.83B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....